The goals of this project will be achieved by the scientific and technological developments in both the medical and technological fields, as detailed by the following three strongly correlated S&T sub-objectives:
- Find new biomarkers and define a suitable multimodal paradigm with already available PET, MR, EEG and PET/MR systems that provides clinical evidence on the feasibility of advanced schizophrenia diagnosis.
- Construct and test an optimized cost-effective trimodality imaging instrument (brain PET/MR/EEG) for diagnosis, monitoring and follow-up of schizophrenia disorders.
- Validate the trimodal imaging device built by this Consortium with regard to the results and the clinical data obtained from objective 1.